PSYCH Symposium 2025
PSYCH Symposium, in partnership with Drug Science, returns to London on December 4th, following the successes of the 2022 and 2023 conferences.
Europe's Landmark Psychedelic Medicine Gathering
At PSYCH Symposium, key figures in science, healthcare, investment, and policy will meet in London for an international conference dedicated to sharing research, discussing policy and improving access to psychedelic medicine. Mental health disorders such as depression, anxiety, PTSD, and addiction affect hundreds of millions worldwide. Conventional treatments, while helpful for many, often fall short, leaving an urgent need for innovation.
About PSYCH Symposium
PSYCH Symposium, a collaboration between PSYCH and Drug Science, is a one-day conference on December 4th, 2025 at Conway Hall in London, bringing together industry leaders to promote the incredible power of psychedelics.
Why London?
The UK is home to world-leading psychedelic research institutions and publicly traded companies, with direct access to London’s capital markets. This lays the foundations for a flourishing domestic industry.
Why Now?
Psychedelic medicines have demonstrated safety and efficacy in clinical trials. Excitement surrounding these treatments has only grown since the 2023 Symposium, making now a perfect time to gather the leaders of the industry.
Speakers Include
Prof David Nutt
Founder, Drug Science
Dr Anne Katrin Schlag
Head of Research, Drug Science
Prof Sunjeev Kamboj
Professor of Translational Clinical Psychology, University College London
Jeff Smith
Member of Parliament for Manchester Withington
Prof Celia Morgan
Chair of Psychopharmacology, University of Exeter
Dr Louise Paterson
Assistant Professor in Psychopharmacology and Psychiatry, Imperial College London
Dr David Erritzoe
Clinical Director, Centre for Psychedelic Research at Imperial College London
Dr Chris Timmermann
Neuroscientist and Psychologist, Imperial College London
Dr Simon Ruffell
Psychiatrist and Founder, Onaya
